By Hanna Vioque ( May 2, 2024, 9:03 PM BST) -- A Kenvue-owned pharmaceutical company has failed to patent a tobacco replacement therapy, after European patent officials ruled that other scientists would have thought of adding a special solution to counteract the slowing effects of saliva pH....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.